Edition:
United States

Chiome Bioscience Inc (4583.T)

4583.T on Tokyo Stock Exchange

425JPY
2:00am EDT
Change (% chg)

¥-4 (-0.93%)
Prev Close
¥429
Open
¥430
Day's High
¥432
Day's Low
¥424
Volume
79,200
Avg. Vol
344,966
52-wk High
¥1,042
52-wk Low
¥415

Latest Key Developments (Source: Significant Developments)

Chiome Bioscience receives patent in US
Tuesday, 14 Mar 2017 02:17am EDT 

Chiome Bioscience Inc <4583.T>:Says it received patent in the U.S. for its product ANTI-HUMAN TROP-2 ANTIBODY HAVING ANTI-TUMOR ACTIVITY IN VIVO.  Full Article

Chiome Bioscience receives patent for METHOD OF INDUCING HOMOLOGOUS RECOMBINATION OF SOMATIC CELL
Tuesday, 10 Jan 2017 01:14am EST 

Chiome Bioscience Inc <4583.T>:Says it received patent grant for METHOD OF INDUCING HOMOLOGOUS RECOMBINATION OF SOMATIC CELL, produced by the co and a Japan-based research institute.  Full Article

Chiome Bioscience to receive patent in New Zealand
Tuesday, 20 Dec 2016 01:18am EST 

Chiome Bioscience Inc <4583.T>:Says it to receive patent in New Zealand for ANTI-HUMAN TROP-2 ANTIBODY HAVING AN ANTITUMOR ACTIVITY IN VIVO.  Full Article

Chiome Bioscience announces exercise of options
Thursday, 15 Dec 2016 03:34am EST 

Chiome Bioscience Inc <4583.T>:Says 1,890 units of its 13th series options were exercised to 1.89 million shares of its common stock from Dec. 6 to Dec. 15.  Full Article

Chiome Bioscience to get patent license from New Zealand
Thursday, 2 Jun 2016 11:02pm EDT 

Chiome Bioscience Inc <4583.T>:Says New Zealand to grant patent license for ANTI-HUMAN TROP-2 ANTIBODY HAVING AN ANTITUMOR ACTIVITY IN VIVO.  Full Article

Chiome Bioscience gets patent license
Wednesday, 25 May 2016 04:15am EDT 

Chiome Bioscience Inc <4583.T>:Says it gets patent license in Europe for METHOD OF INDUCING HOMOLOGOUS RECOMBINATION OF SOMATIC CELL.  Full Article

Chiome Bioscience announces result of early-retirement program
Friday, 20 May 2016 04:06am EDT 

Chiome Bioscience Inc <4583.T>:Says 8 employees took up the offer of the early-retirement program announced on Feb. 12.  Full Article

Chiome Bioscience to get patent for TROP-2 antibody in Korea
Tuesday, 22 Mar 2016 04:50am EDT 

Chiome Bioscience Inc:Says its received notification of decision that to grant patent for TROP-2 antibody in Korea.Says TROP-2 antibody is used to inhibit cancer growth.  Full Article

Chiome Bioscience gets patent for TROP-2 antibody in U.S
Wednesday, 16 Mar 2016 02:00am EDT 

Chiome Bioscience Inc:Got patent for TROP-2 antibody in U.S.TROP-2 antibody is a monoclonal antibody to inhibit cancer growth.  Full Article

Chiome Bioscience to offer early-retirement program
Monday, 15 Feb 2016 01:30am EST 

Chiome Bioscience Inc:To offer an early-retirement program to 60 employees.Offering time from middle May.The company expects 11 employees to take up the offer.Says the employees who take up the offer will retire on June 30.The company will provide retirement payment to the retiring employees.  Full Article

More From Around the Web

BRIEF-Chiome Bioscience receives patent in US

* Says it received patent in the U.S. for its product ANTI-HUMAN TROP-2 ANTIBODY HAVING ANTI-TUMOR ACTIVITY IN VIVO